" U.S. pharmaceutical giant Pfizer Inc. applied for approval of its COVID-19 vaccine to the Japanese Health, Labor and Welfare Ministry on Friday, making it the first supplier to formally do so in the nation. If approved, the vaccination could likely be available in Japan as early as this fiscal year, which ends in March.
Vaccinations began in Britain on Dec. 8 and in the United States on Monday for medical professionals and the elderly.
It normally takes about a year for a drug to be approved, but the ministry had the pharmaceuticals and medical devices law revised in May so that a fast-track system can quickly approve drugs related to the novel coronavirus. This means the vaccine could gain approval in Japan within a few months. "
Чтоб сразу разрешить и начать применять вакцину разрешённую FDA и в Европе - это слабо оказалось.
> 15
Barr всегда работал ген.прокурором у респ.президентов проигрывающих свой 1й срок
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
no subject
"
U.S. pharmaceutical giant Pfizer Inc. applied for approval of its COVID-19 vaccine to the Japanese Health, Labor and Welfare Ministry on Friday, making it the first supplier to formally do so in the nation. If approved, the vaccination could likely be available in Japan as early as this fiscal year, which ends in March.
Vaccinations began in Britain on Dec. 8 and in the United States on Monday for medical professionals and the elderly.
It normally takes about a year for a drug to be approved, but the ministry had the pharmaceuticals and medical devices law revised in May so that a fast-track system can quickly approve drugs related to the novel coronavirus. This means the vaccine could gain approval in Japan within a few months.
"
Чтоб сразу разрешить и начать применять вакцину разрешённую FDA и в Европе - это слабо оказалось.
> 15
Barr всегда работал ген.прокурором у респ.президентов проигрывающих свой 1й срок